Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29374392)

  • 21. Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma.
    Huang Y; Chen X; Chen N; Nie L; Xu M; Zhou Q
    J Clin Pathol; 2011 Nov; 64(11):953-9. PubMed ID: 21730264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M; Peraud A; Leroch B; Kreth FW
    Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas.
    Adamkov M; Halasova E; Rajcani J; Bencat M; Vybohova D; Rybarova S; Galbavy S
    Med Sci Monit; 2011 Feb; 17(3):BR74-80. PubMed ID: 21358596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance?
    Mulay K; Shah SJ; Aggarwal E; White VA; Honavar SG
    Acta Ophthalmol; 2014 Dec; 92(8):e681-7. PubMed ID: 24930483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent astrocytic tumours--a study of p53 immunoreactivity and malignant progression.
    Sarkar C; Ralte AM; Sharma MC; Mehta VS
    Br J Neurosurg; 2002 Aug; 16(4):335-42. PubMed ID: 12389885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of immunohistochemistry in predicting behavior of astrocytic tumors.
    Ambroise MM; Khosla C; Ghosh M; Mallikarjuna VS; Annapurneswari S
    Asian Pac J Cancer Prev; 2010; 11(4):1079-84. PubMed ID: 21133628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic evaluation in supratentorial astrocytic tumors using p53, epidermal growth factor receptor, c-erbB-2 immunostaining.
    Hwang SL; Hong YR; Chai CY; Lin HJ; Howng SL
    Kaohsiung J Med Sci; 1998 Oct; 14(10):607-15. PubMed ID: 9819502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy.
    Yu JI; Lee H; Park HC; Choi DH; Choi YL; Do IG; Kim HC; Lee WY; Yun SH; Cho YB; Huh JW; Park YA; Park YS; Park JO; Kim ST; Park W
    Oncotarget; 2016 Sep; 7(38):62676-62686. PubMed ID: 27391438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
    Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.
    Jha P; Agarwal S; Pathak P; Srivastava A; Suri V; Sharma MC; Chosdol K; Srivastava T; Gupta D; Gupta A; Suri A; Sarkar C
    Cancer Genet Cytogenet; 2010 Apr; 198(2):126-34. PubMed ID: 20362227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
    Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
    Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.
    Bongiovanni L; Mazzocchetti F; Malatesta D; Romanucci M; Ciccarelli A; Buracco P; De Maria R; Palmieri C; Martano M; Morello E; Maniscalco L; Della Salda L
    BMC Vet Res; 2012 Jun; 8():78. PubMed ID: 22686277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors.
    Lange F; Kaemmerer D; Behnke-Mursch J; Brück W; Schulz S; Lupp A
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1227-1237. PubMed ID: 29696364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
    Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors.
    Bian XW; Shi JQ; Liu FX
    Anal Quant Cytol Histol; 2000 Dec; 22(6):429-37. PubMed ID: 11147296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy.
    Hilton DA; Love S; Barber R; Ellison D; Sandeman DR
    Neurosurgery; 1998 Apr; 42(4):724-9. PubMed ID: 9574635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Centroblastic diffuse large B cell lymphoma displays distinct expression pattern and prognostic role of apoptosis resistance related proteins.
    Faccion RS; Rezende LM; Romano Sde O; Bigni Rde S; Mendes GL; Maia RC
    Cancer Invest; 2012 Jun; 30(5):404-14. PubMed ID: 22571341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.